1. Academic Validation
  2. Synthesis and biological activity of C-7, C-9 and C-10 modified taxane analogues from 1-deoxybaccatin VI

Synthesis and biological activity of C-7, C-9 and C-10 modified taxane analogues from 1-deoxybaccatin VI

  • Bioorg Med Chem. 2020 Nov 1;28(21):115736. doi: 10.1016/j.bmc.2020.115736.
Chenghu Xie 1 Yongmei Cui 1 Lanlan Li 2 Minmin Zhang 2 Hongchun Liu 3 Haixia Lin 4
Affiliations

Affiliations

  • 1 Department of Chemistry, Innovative Drug Research Center, College of Sciences, Shanghai University, Shanghai, China.
  • 2 Division of Anti-tumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
  • 3 Division of Anti-tumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China. Electronic address: hchliu@simm.ac.cn.
  • 4 Department of Chemistry, Innovative Drug Research Center, College of Sciences, Shanghai University, Shanghai, China. Electronic address: haixialin@staff.shu.edu.cn.
Abstract

A series of C-7, C-9 and C-10 modified taxane analogues were synthesized and their in vitro Anticancer activities against three human Cancer cell lines: A-549 (human lung Cancer cell line), MDA-MB-231 (human breast Cancer cell line), A-549/T (human lung Cancer resistant cell line) were studied. The novel 1-deoxybaccatin VI derivatives modified with carbonate group at C-9 and C-10 positions enable the behavior of these compounds to be evidently distinct from Other similar compounds. The strong cytotoxicity in the three cell lines, especially in drug-resistant cell line, showed by the newly synthesized taxane analogues indicated them as potential lead compounds for Anticancer drug design.

Keywords

1-Deoxybaccatin VI; In vitro anticancer activity; Paclitaxel; Synthesis; Taxane analogues.

Figures